Job Opportunities API

The Public Ledger of Openings

← Back to the ledger

Director, Controller

Braveheart Bio
CompanyBraveheart Bio
CategoryFinance
LocationSan Francisco
RemoteHybrid
EmploymentNot stated
LevelDirector
SalaryNot stated by the employer
Posted17 Jul 2026
Last verified31 Jul 2026
SourceEmployer career page (greenhouse)
Applications are handled by the employer, not by us.Apply on the employer's site →
Description
About us: Braveheart Bio is a clinical-stage biopharmaceutical company focused on developing therapies for patients with hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases. Our lead product candidate, BHB-1893, is a next-generation oral small-molecule cardiac myosin inhibitor (CMI) being developed for the treatment of obstructive HCM (oHCM) and non-obstructive HCM (nHCM). Braveheart’s goal is to improve the treatment options for these patients by enhancing speed of onset, depth of gradient response, systolic safety, reversibility and reducing prescribing complexity. With a proven leadership team, a strong financial foundation, and a high-value late-stage asset, Braveheart Bio represents an outstanding opportunity for ambitious, mission-driven professionals to make a tangible impact in a high-profile and rapidly evolving therapeutic area.   The role:   The Director, Controller is an experienced leader that will build and run the financial infrastructure of our fast-moving clinical-stage biotechnology company. Reporting to the VP of Finance, this individual will own day-to-day accounting operations and related internal controls, including month-end, quarter-end, and year-end close processes, as well as lead necessary system implementations to support the Company’s continued growth. This is a hands-on role that will collaborate with various internal and external partners, including non-finance operating teams.     Key responsibilities:   Own  the  monthly, quarterly, and annual close proces s   to ensure  accurate  financial statements on a timeline that meets  internal and external  reporting deadlines.   Oversee  the majority of  GL accounts including  Cash,  Prepaids,  R&D  and clinical  trial  accruals ,  and  G&A accruals .     Develop and own the clinical trial accrual process including reviewing clinical contracts, CRO reports, patient costs, site costs, and invoices for timely and proper accrual. Liaise directly with clinical vendors to ensure completeness and accuracy.   Manage accounts payable   and cash disbursements  to ensure  timely  and  accurate  payments to our vendors.   Supervise and review multi-state payroll process (semi-monthly) to ensure all employees are paid  timely  and accurately .   Coordinate with FP&A  to  support  their budgeting and forecasting  needs  and  their  creation of budget vs actuals , including ensuring  timely  and  accurate   reporting  of   actuals .     Develop  and  maintain  accounting policies, procedures, and internal controls  that can scale through an IPO and beyond .   Evaluate, implement, and  optimize  financial systems ,   including  Netsuite  and a new  payrol l  system .   Coordinate with legal and HR on tax compliance   and regulatory filings .   Support  relationships with external accounting, tax, and payroll service providers .   Assist  in the hiring  and develop ment of  a small, high-performing accounting and finance team as the company scales     Required experience & skills:   8-12 years of progressive finance and accounting experience, with at least 5 years at a publicly traded or pre-IPO biotech or life sciences company   De
HOUSE AD1,014,484 openings. Erioun finds yours.Scored against your own profile, every hour.Try the radar →
Director, Controller — Braveheart Bio · Job Opportunities API